Skip to main content

Home
OUR XCHANGES
- LIFE SCIENCES
  - BY TOPIC
  - BY LOCATION
    - BOSTON, USA
    - SAN FRANCISCO, USA
- INSURANCE
  - INSURANCE INNOVATION EUROPE 2026
- PAST EVENTS
INDUSTRY EXPERTS
NEWS XCHANGE
PARTNERSHIPS
ABOUT US

Home
OUR XCHANGES
- LIFE SCIENCES
  - BY TOPIC
  - BY LOCATION
    - BOSTON, USA
    - SAN FRANCISCO, USA
- INSURANCE
  - INSURANCE INNOVATION EUROPE 2026
- PAST EVENTS
INDUSTRY EXPERTS
NEWS XCHANGE
PARTNERSHIPS
ABOUT US

Sponsorship Enquiry
Register For Free

Home
OUR XCHANGES
- LIFE SCIENCES
  - BY TOPIC
  - BY LOCATION
    - BOSTON, USA
    - SAN FRANCISCO, USA
- INSURANCE
  - INSURANCE INNOVATION EUROPE 2026
- PAST EVENTS
INDUSTRY EXPERTS
NEWS XCHANGE
PARTNERSHIPS
ABOUT US

Antibody Therapeutics Xchange - San Francisco - 2026

Loading

Optimizing linkers and conjugation technologies to reduce ADC toxicities

02 Sept 2026

09:05 - 10:05

ADC Linker Design & Conjugation Technologies

hubXchange

27 Old Gloucester Street

London
WC1N 3AX

+44 20 33552139
info@hub-xchange.com

About

hubXchange specialises in delivering high-level content, intelligence and connections to the global life sciences community by hosting outstanding business Xchanges.

Links

About Company
Our Xchanges
Industry Experts
Partnerships
Terms & Conditions
Contact Us

Hubxchange logo

Company Details

© 2017 HUB XCHANGE LIMITED. All Rights Reserved. Registered Office: 27 Old Gloucester Street, London, England, WC1N 3AX VAT Registration No. 281308022 - Registered in England No. 10714971

© Copyright 2025

Exhibition Website by ASP

LinkedIn
YouTube
Search

Search

Username *

Password *